Jefferies Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $16.9M | Buy |
126,000
+6,700
| +6% | +$961K | 0.14% | 113 |
|
|
2022
Q2 | $18.3M | Buy |
119,300
+83,300
| +231% | +$12.7M | 0.15% | 99 |
|
|
2022
Q1 | $5.84M | Buy |
36,000
+10,000
| +38% | +$1.45M | 0.04% | 374 |
|
|
2021
Q4 | $3.52M | Hold |
26,000
| – | – | 0.02% | 592 |
|
|
2021
Q3 | $2.8M | Buy |
+26,000
| New | +$2.97M | 0.02% | 629 |
|
|
2021
Q1 | – | Sell |
-1,500
| Closed | -$161K | – | 1577 |
|
|
2020
Q4 | $161K | Hold |
1,500
| – | – | ﹤0.01% | 1409 |
|
|
2020
Q3 | $131K | Hold |
1,500
| – | – | ﹤0.01% | 1221 |
|
|
2020
Q2 | $147 | Sell |
1,500
-159,400
| -99% | -$14M | ﹤0.01% | 1090 |
|
|
2020
Q1 | $12.3M | Sell |
160,900
-41,100
| -20% | -$3.5M | 0.14% | 128 |
|
|
2019
Q4 | $17.9M | Buy |
202,000
+67,200
| +50% | +$5.58M | 0.14% | 127 |
|
|
2019
Q3 | $10.2M | Buy |
134,800
+61,300
| +83% | +$4.2M | 0.08% | 216 |
|
|
2019
Q2 | $5.34M | Buy |
73,500
+18,600
| +34% | +$1.46M | 0.04% | 438 |
|
|
2019
Q1 | $4.42M | Sell |
54,900
-41,400
| -43% | -$3.39M | 0.04% | 494 |
|
|
2018
Q4 | $8.88M | Buy |
96,300
+18,800
| +24% | +$1.65M | 0.07% | 220 |
|
|
2018
Q3 | $7.33M | Sell |
77,500
-63,400
| -45% | -$6.01M | 0.05% | 381 |
|
|
2018
Q2 | $13.1M | Buy |
140,900
+8,400
| +6% | +$820K | 0.07% | 201 |
|
|
2018
Q1 | $12.5M | Sell |
132,500
-63,700
| -32% | -$7M | 0.07% | 203 |
|
|
2017
Q4 | $19M | Sell |
196,200
-216,900
| -53% | -$20.4M | 0.09% | 139 |
|
|
2017
Q3 | $36.7M | Buy |
413,100
+147,700
| +56% | +$11.2M | 0.24% | 56 |
|
|
2017
Q2 | $19.2M | Sell |
265,400
-221,400
| -45% | -$14.9M | 0.13% | 132 |
|
|
2017
Q1 | $31.7M | Buy |
486,800
+308,500
| +173% | +$19.4M | 0.24% | 62 |
|
|
2016
Q4 | $11.2M | Buy |
178,300
+118,300
| +197% | +$7.22M | 0.06% | 310 |
|
|
2016
Q3 | $3.78M | Buy |
+60,000
| New | +$3.88M | 0.02% | 633 |
|
|
2016
Q2 | – | Sell |
-108,000
| Closed | -$6.17M | – | 2092 |
|
|
2016
Q1 | $6.17M | Sell |
108,000
-215,400
| -67% | -$12M | 0.04% | 416 |
|
|
2015
Q4 | $19.2M | Buy |
323,400
+57,900
| +22% | +$3.33M | 0.11% | 151 |
|
|
2015
Q3 | $14.4M | Hold |
265,500
| – | – | 0.08% | 183 |
|
|
2015
Q2 | $17.8M | Sell |
265,500
-87,500
| -25% | -$5.71M | 0.09% | 181 |
|
|
2015
Q1 | $20.7M | Sell |
353,000
-32,100
| -8% | -$1.94M | 0.12% | 113 |
|
|
2014
Q4 | $25.2M | Buy |
385,100
+176,700
| +85% | +$11.1M | 0.15% | 119 |
|
|
2014
Q3 | $12M | Sell |
208,400
-41,600
| -17% | -$2.31M | 0.08% | 209 |
|
|
2014
Q2 | $14.1M | Buy |
250,000
+70,000
| +39% | +$3.67M | 0.12% | 153 |
|
|
2014
Q1 | $9.25M | Buy |
180,000
+179,700
| +59,900% | +$9.08M | 0.09% | 179 |
|
|
2013
Q4 | $16K | Buy |
+300
| New | +$14.7K | ﹤0.01% | 1795 |
|
Other funds holding ABBV
Jefferies Group's ABBV Position: Q3 2022 in Review
Jefferies Group increased its AbbVie (ABBV) stake by 32% in Q3 2022, buying an estimated $2.44M and bringing the position to 70,155 shares worth $9.42M. The position accounts for 0.08% of the portfolio, ranked #199.
Jefferies Group first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $18.1M in Q2 2018. 2,968 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.
- Jefferies Group held 70,155 shares of AbbVie worth $9.42M as of Q3 2022.
- Jefferies Group bought 16,993 AbbVie shares in Q3 2022, an estimated $2.44M.
- AbbVie made up 0.08% of Jefferies Group's portfolio in Q3 2022, its #199 holding.
- Jefferies Group first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Jefferies Group's AbbVie position peaked at $18.1M in Q2 2018.
- 2,968 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.
Based on Jefferies Group's 13F filing for Q3 2022, filed 14 Nov 2022.